Michael Goller

Director at Terremoto Biosciences

Capital raised by Terremoto Biosciences

$40.7M+$40.7M latest round

1 Form D filing · first filed Apr 2026 · South San Francisco, CA

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2022
30D INTEREST: —

Career

1 company on file · founded 2022

Terremoto BiosciencesBiotech · South San Francisco, CAsince 2022

Director

Listed on Terremoto Biosciences's Form D filings

Company filings

via EDGAR · Form D for Terremoto Biosciences1

DateCompanyFormAmountRole on filing

Apr 10, 2026Terremoto BiosciencesForm D+$40.7M—

Form DApr 10, 2026 · Terremoto Biosciences+$40.7Mnot a signer

Overview

Last filing Apr 10, 2026

Michael Goller is on file as Director at Terremoto Biosciences in South San Francisco, CA. Terremoto Biosciences has 1 Form D filing on record, $40.7M raised in total.

Teammates

Terremoto Biosciences · 1

James ChristensenPresidentSigner

Products

Terremoto Biosciences · 1

TER-2013Clinical-stage oncology therapeutic

An orally available, AKT1-selective small-molecule inhibitor in a Phase 1 clinical trial (NCT-07109726) for breast cancer and other solid tumors carrying PI3K/AKT/PTEN pathway alterations.